Panomics

Curated by Signal

Provider of multi-omics data analysis platform for drug development

Overview

Provider of multi-omics data analysis platform for drug development. It integrates genomics, transcriptomics, proteomics, and metabolomics data that enables the analysis of complex biological data sets, providing valuable insights for precision medicine, personalized healthcare, and drug discovery.

Key facts

Founded: 2022
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Business model

10 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

CuresDev
Provider of a rare disease data sharing platform
Health TechnologySan Jose, United States
7MinGym
App for fitness training
Health TechnologyMountain View, United States
BlazeMD
Provider of an online medical marijuana card
Health TechnologyJamaica, United States

About Panomics

What does Panomics do?

Provider of multi-omics data analysis platform for drug development.

Where is Panomics headquartered?

Panomics is headquartered in New York City, United States.

When was Panomics founded?

Panomics was founded in 2022.

Which sector is Panomics in?

Panomics operates in Health Technology.

Who are Panomics's competitors?

Companies similar to Panomics include CuresDev, 7MinGym, and BlazeMD.